Clearsynth

Mumbai, India Founded: 2009 • Age: 17 yrs Minicorn
CDMO focused on manufacturing of pharmaceutical small molecules and analytical research services

About Clearsynth

Clearsynth is a Healthcare company based in Mumbai (India) founded in 2009 by Vijay Ambati. CDMO focused on manufacturing of pharmaceutical small molecules and analytical research services. Clearsynth has raised $4.81 million across 2 funding rounds from investors including SIDBI Venture Capital and Tulip Diagnostics. The company has 267 employees. Clearsynth was last valued at $49.85 million in February 2022. Its chief executive, as recorded, is Vijay Ambati. Its website clearsynth.com draws about 21 thousand monthly visits. Its Indian entity Clearsynth Labs Limited reported revenue of β‚Ή175 Cr. Its focus areas include Biopharma Outsourcing, Diversified and Small Molecules & Peptides.

Company details

Clearsynth was founded in 2009 in Mumbai, India, as a contract development and manufacturing organization (CDMO) in the pharmaceutical sector. Operations center on the production of small molecule active pharmaceutical ingredients (APIs) alongside analytical research and development services. These activities support global clients through custom synthesis, process development, and quality control testing, with facilities located in India to ensure regulatory compliance and scalable manufacturing.

  • Headquarters Mumbai, India
  • Employees 267
  • Founders Vijay Ambati
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website clearsynth.com
  • Social LinkedIn X Facebook YouTube
  • Legal Name Clearsynth Labs Limited
  • Date of Incorporation 30 Mar, 2010
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹175 Cr

    FY 2024 · +86% YoY

  • Net Profit
    ₹9.41 Cr

    FY 2024 · 5% margin

  • EBITDA
    ₹25.21 Cr

    FY 2024 · 14% margin

  • Total Equity Funding
    $4.81M (USD)

    in 2 rounds

  • Latest Funding Round
    $4.4M (USD), Series A

    Feb 2022

  • Investors
  • Employee Count
    267

Apps and channels of Clearsynth

its YouTube channel Clearsynth has 77 subscribers and 29 videos.

Clearsynth
YouTube 77 subscribers 29 videos Science & Technology
Open channel

Videos from Clearsynth

The most watched videos on Clearsynth's YouTube channel, Clearsynth (77 subscribers). Click a video to play it here.

Clearsynth Hyderabad Research Centre
1.1K views
Vijay Ambati (Founder & Group CEO)
633 views
Clearsynth Mumbai Office
615 views
All about "CLEARSYNTH"
488 views

More on Clearsynth.

Funding Insights of Clearsynth

Clearsynth has successfully raised a total of $4.81M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.4 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $4.81M
  • Total Rounds 2
  • Last Round Series A β€” $4.4M
  • First Round $406,551

    (Sep 2020)

  • Investors Count 2

All 2 funding rounds of Clearsynth with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2022$4.4MSeries A$49.85MTulip Diagnostics
–
Sep 2020$406,551Seed$9.85MSIDBI Venture Capital
–
Valuation history
DateValuationStage
Feb 2022$49.85Mβ€’β€’β€’β€’β€’β€’β€’β€’
Sep 2020$9.85Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $49.85M (Feb 2022). 2 investors in total: 2 institutional.

Investors in Clearsynth

Clearsynth has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include SIDBI Venture Capital and Tulip Diagnostics.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital management for SMEs and startups in India.
1999sidbiventure.co.inMumbai, India
IVD kits and instruments for infectious diseases and clinical chemistry
1988tulipgroup.comPanaji, India
Premium access

Investor details for Clearsynth

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Clearsynth Labs Limited (Clearsynth)

Clearsynth Labs Limited is the primary company behind Clearsynth. The board of Clearsynth Labs Limited currently have 3 directors; the longest-serving is Vijay Kumar Ambati, appointed in 2010. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vijay Kumar Ambati
DIN 00698295
Whole-time director30 Mar 201016 yrs 7 moClearsynth Labs Limited
Suman Vijay Ambati
DIN 03177651
Whole-time director14 Aug 201016 yrs 3 moClearsynth Labs Limited
Vishwanatham Ambati
DIN 06923460
Director12 Aug 201412 yrs 3 moClearsynth Labs Limited

People of Clearsynth

14 people are tracked at Clearsynth (4 in leadership, 10 in team); the tracked headcount is 267.

NameRoleGroup
Founder & CEOLeadership
Bhakti Prabhu
Assistant Director - Project & Operations, DeuteroLeadership
Praveen Ramaraju
Group Head - Chemistry ServicesLeadership
Purnanand Kumbhalkar
Senior Group Head - Chemistry ServicesLeadership
Paramesh Gangajji
Principal ScientistTeam
Dr. Vipin Kumar Pandey
Research And Development ScientistTeam
Intern Marketing | Clearsynth
internTeam
Santhosh Subramanian
Senior ScientistTeam
Krishna Sharma
Business Operation CDMOTeam
Akash Bhajibhakare
Research AssociateTeam
Sukanya Pookatill
Nitrosamines Specialist (global Market)Team
Ashwini Chougule
Senior ChemistTeam
Dr Makthala Ravi
Senior ScientistTeam
Deepak More
Research AssociateTeam
Premium access

Complete people profiles for Clearsynth

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Clearsynth

Figures of Clearsynth Labs Limited, the primary company behind Clearsynth, for FY 2024. Revenue was ₹175 Cr (+86% year on year). Net profit was ₹9.41 Cr (5% margin). EBITDA was ₹25.21 Cr (14% margin). Revenue has grown at a compounded annual rate of +68% over three years and +37% over five years.

  • ₹175 CrRevenue · FY 2024 · +86% YoY
  • ₹9.41 CrNet profit · 5% margin
  • ₹25.21 CrEBITDA · 14% margin
  • ₹1.73 CrPaid-up capital
  • 267Employees (provident fund records)
  • +68%Revenue CAGR, 3 years
  • +37%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Clearsynth Labs Limited are on its company page.

Premium access

Detailed financial statements for Clearsynth

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Clearsynth

4 dated milestones of Clearsynth across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded Clearsynth is founded.
  2. Funding First funding round of $407K.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Series A, of $4.4M.

Web traffic of Clearsynth

The website of Clearsynth (clearsynth.com) receives about 20.6K visits a month.

  • Monthly visits
    20.6K

    ▲ 31.4% vs previous month

Similar websites

Websites whose visitors overlap most with Clearsynth. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
synzeal.com
100%
28.2K#1,009,493View details
pharmaffiliates.com
pharmaffiliates.com
84%
#502,789–
alsachim.com
81%
1.7K#11,614,490View details
fishersci.ch
fishersci.ch
78%
#1,040,824–
lgcstandards.com
78%
228.5K#179,043View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 28 similar websites and full traffic analytics for Clearsynth

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 28 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Clearsynth (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Clearsynth

Premium access

Complete news archive for Clearsynth

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Clearsynth

Clearsynth was founded in 2009 and raised its 1st funding round 11 years after it was founded.

Clearsynth is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Vijay Ambati is the CEO of Clearsynth, as recorded in our data. They have also founded this company.

Clearsynth is a funded company, having raised a total of $4.81M across 2 funding rounds to date. The company's 1st funding round was a Seed of $406.55K, raised on Sep 2020.

Clearsynth has 267 employees.

The primary company behind Clearsynth, Clearsynth Labs Limited, reported revenue of β‚Ή175 Cr for FY 2024, up 86% year on year.

Clearsynth was founded in 2009 in Mumbai, India, as a contract development and manufacturing organization (CDMO) in the pharmaceutical sector. Operations center on the production of small molecule active pharmaceutical ingredients (APIs) alongside analytical research and development services. These activities support global clients through custom synthesis, process development, and quality control testing, with facilities located in India to ensure regulatory compliance and scalable manufacturing.

Clearsynth has 2 investors. Key investors include SIDBI Venture Capital, and Tulip Diagnostics.

The valuation of Clearsynth is $49.85M as of Feb 2022.

Clearsynth operates through Clearsynth Labs Limited.

The legal entities of Clearsynth currently have 3 directors, including Vishwanatham Ambati, Suman Vijay Ambati, Vijay Kumar Ambati.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available